BiotechTube
Home/SonoMotion/Emily Hergenreter
EH

Emily Hergenreter

VP of Clinical Affairs

SonoMotion

Therapeutic Areas

UrologyNephrology

SonoMotion Pipeline

DrugIndicationPhase
Break WaveFragmentation of kidney stonesApproved
Stone ClearRepositioning of post-lithotripsy kidney stone fragmentsUnknown

Leadership Team at SonoMotion

OL
Oren Levy, PhD
Chief Executive Officer, Co-Founder
DC
Doug Corl, PhD
Chief Technology Officer
View full SonoMotion profile